Last reviewed · How we verify
Placebo to match danazol — Competitive Intelligence Brief
phase 3
Oncology
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo to match danazol (Placebo to match danazol) — Sierra Oncology LLC - a GSK company. This is a placebo formulation designed to match the appearance and administration of danazol for use as a control in clinical trials.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo to match danazol TARGET | Placebo to match danazol | Sierra Oncology LLC - a GSK company | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo to match danazol CI watch — RSS
- Placebo to match danazol CI watch — Atom
- Placebo to match danazol CI watch — JSON
- Placebo to match danazol alone — RSS
Cite this brief
Drug Landscape (2026). Placebo to match danazol — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-to-match-danazol. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab